South Korea ECG Market Size, Trends, Growth & Outlook

South Korea ECG Market by Product (Resting ECG, Stress ECG, and Holter Monitors) Lead (Single Lead ECG, 3-6 Lead ECG, and 12 Lead ECG) and End User (Hospitals & Clinics, Home Settings & Ambulatory Surgical Centers, and Others): Opportunity Analysis and Industry Forecast, 2017 - 2025

Industry: Life Science | Report ID: FAMI-00217 | Published on: Sep, 2019 | View: 248 | Share:         

Request Sample Enquire Before Buying Request Discount

  • Report Descripton
  • Table Of Content
  • Request Methodology
  • Request Customization

Electrocardiograph (ECG) devices are used to record the heart activities through electric signals. These devices are amplified on the ECG monitor. They are essentially adopted across various medical set-ups to diagnose different types of heart diseases and arrhythmias in people; thereby, assisting the appropriate therapy for patients suffering from cardiovascular diseases (CVD). The South Korea ECG market was valued at $2.99 million in 2017 and is expected to reach $7.69 million by 2025, registering a CAGR of 12.3% from 2017 to 2025.

The key factors that drive the market growth include increase in number of CVD patients across South Korea and rise in demand for monitoring systems and portable cardiac rhythm management. In addition, surge in the geriatric population and favorable government regulations regarding the ECG devices supplement the market growth in South Korea. However, high costs associated with sophisticated ECG devices and increase in threat of market saturation are the factors anticipated to restrict the market growth. Conversely, increase in development of wireless communication and cloud computing is expected to provide lucrative opportunities for the growth of the market.

The South Korea ECG market is segmented into product, lead, and end user. Based on product, the market is divided into resting ECG, stress ECG, and Holter monitors. The Holter monitors are further bifurcated into wired and wireless Holter monitors. Based on lead, the market is classified into single lead, 3-6 lead, and 12-lead. Based on end user, it is categorized into hospitals & clinics, home settings & ambulatory surgical centers (ASCs), and others.

Key Market Benefits for ECG market:

    The study provides an in-depth analysis of the ECG devices and instruments, with current trends and future estimations to elucidate the imminent investment pockets.

    A quantitative analysis from 2017 to 2025 is discussed to enable the stakeholders to capitalize on the prevailing market opportunities.

    Key players are profiled and their strategies are analyzed thoroughly to understand the competitive outlook of the market.

    Porter’s five forces model is expected to interpret the bargaining power of suppliers & buyers, threat of new entrants & substitutes, and competition among the key players.

ECG Key Market Segments:

By Product

    Resting ECGs
    Stress ECGs
    Holter Monitors
    Wired Holter Monitors
    Wireless Holter Monitors

By Lead

    Single Lead
    3-6 Lead
    12 Lead

By End User

    Hospitals & Clinics
    Home settings and Ambulatory surgical centers
    Others

The list of key players operating in this market includes:

    GE Healthcare (General Electric Company)
    Bionet Co., Ltd.
    Hill Rom Holdings, Inc.
    Koninklijke Philips N.V.
    Mediana Co., Ltd.
    Medtronic Plc.
    Mindray Medical International Limited
    Nihon Kohden Corporation
    OSI Systems Inc.
    Schiller AG
    CardioComm Solutions, Inc.
    AlivCor, Inc.
    Qardio, Inc.
    Omron Healthcare Europe B.V
    Beijing Choice Electronic Technology Co., Ltd. (ChoiceMMed)

The other players included in the value chain analysis (and not included in the report) include:

    Trismed Co., Ltd
    Johnson & Johnson
    Midmark Corporation
    Fukuda Denshi Co., Ltd

Get a sample pages of this report Click here

"CHAPTER 1: INTRODUCTION

1.1. Report description
1.2. Key benefits for stakeholders
1.3. Key market segments
1.4. Research methodology

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2: EXECUTIVE SUMMARY

2.1. CXO perspective

CHAPTER 3: MARKET OVERVIEW

3.1. Market definition and scope
3.2. Key findings

3.2.1. Top investment pockets

3.3. Top player positioning, 2017
3.4. Porters five forces analysis
3.5. Market dynamics

3.5.1. Drivers

3.5.1.1. Rise in geriatric population in South Korea
3.5.1.2. Favorable government regulations
3.5.1.3. Technological advancements and portability of ECG devices

3.5.2. Restraints

3.5.2.1. High cost associated with ECG devices
3.5.2.2. Unfavorable economic conditions and market saturation

3.5.3. Opportunity

3.5.3.1. Increase in development of wireless communications and cloud computing

3.6. OTC ECG Devices Market

3.6.1. Overview
3.6.2. Market size and forecast

CHAPTER 4: SOUTH KOREA ELECTROCARDIOGRAPH (ECG) MARKET, BY PRODUCT

4.1. Overview

4.1.1. Market Size and Forecast

4.2. Resting ECG

4.2.1. Key market trends and growth opportunities
4.2.2. Market Size & Forecast

4.3. Stress ECG

4.3.1. Key market trends and growth opportunities
4.3.2. Market Size & Forecast

4.4. Holter Monitors

4.4.1. Key market trends and growth opportunities
4.4.2. Market Size and Forecast, by Product Type
4.4.3. Market Size & Forecast

4.4.3.1. Wired Holter monitors

4.4.3.1.1. Market size & forecast

4.4.3.2. Wireless Holter monitors

4.4.3.2.1. Market size & forecast

CHAPTER 5: SOUTH KOREA ELECTROCARDIOGRAPH (ECG) MARKET, BY LEAD

5.1. Overview

5.1.1. Market Size and Forecast

5.2. Single Lead ECG

5.2.1. Market Size & Forecast

5.3. 3-6 Lead ECG

5.3.1. Market Size & Forecast

5.4. 12-Lead ECG

5.4.1. Market Size & Forecast

CHAPTER 6: SOUTH KOREA ELECTROCARDIOGRAPH (ECG) MARKET, BY END USER

6.1. Overview

6.1.1. Market size and forecast

6.2. Hospitals & Clinics

6.2.1. Market Size & Forecast

6.3. Home Settings & Ambulatory Surgical Centers (ASCs)

6.3.1. Market Size & Forecast

6.4. Others

6.4.1. Market Size & Forecast

CHAPTER 7: COMPANY PROFILES

7.1. BIONET CO., LTD.

7.1.1. Company overview
7.1.2. Company snapshot
7.1.3. Operating business segments
7.1.4. Product Portfolio

7.2. GE HEALTHCARE (GENERAL ELECTRIC)

7.2.1. Company overview
7.2.2. Company snapshot
7.2.3. Operating business segments
7.2.4. Product Portfolio
7.2.5. Business performance
7.2.6. Key strategic moves and developments

7.3. HILL ROM HOLDINGS, INC.

7.3.1. Company overview
7.3.2. Company snapshot
7.3.3. Operating business segments
7.3.4. Product Portfolio
7.3.5. Business performance
7.3.6. Key strategic moves and developments

7.4. KONINKLIJKE PHILIPS N.V.

7.4.1. Company overview
7.4.2. Company snapshot
7.4.3. Operating business segments
7.4.4. Business performance
7.4.5. Product Portfolio
7.4.6. Key strategic moves and developments

7.5. MEDIANA CO., LTD

7.5.1. Company overview
7.5.2. Company snapshot
7.5.3. Operating business segments
7.5.4. Product Portfolio

7.6. MEDTRONIC PLC.

7.6.1. Company overview
7.6.2. Company snapshot
7.6.3. Operating business segment
7.6.4. Product Portfolio
7.6.5. Business performance
7.6.6. Key strategic moves and developments

7.7. MINDRAY MEDICAL INTERNATIONAL LIMITED

7.7.1. Company overview
7.7.2. Operating business segment
7.7.3. Product Portfolio

7.8. NIHON KOHDEN CORPORATION

7.8.1. Company overview
7.8.2. Company snapshot
7.8.3. Operating business segments
7.8.4. Product Portfolio
7.8.5. Business performance

7.9. OSI SYSTEMS, INC.

7.9.1. Company overview
7.9.2. Company snapshot
7.9.3. Operating business segments
7.9.4. Product Portfolio
7.9.5. Business performance

7.10. SCHILLER AG

7.10.1. Company overview
7.10.2. Company snapshot
7.10.3. Operating business segment
7.10.4. Product Portfolio

7.11. ALIVCOR, INC.

7.11.1. Company overview
7.11.2. Company snapshot
7.11.3. Product Portfolio

7.12. BEIJING CHOICE ELECTRONIC TECHNOLOGY CO., LTD (CHOICEMMED)

7.12.1. Company overview
7.12.2. Company snapshot
7.12.3. Product Portfolio

7.13. CARDIOCOMM SOLUTIONS, INC.

7.13.1. Company overview
7.13.2. Company snapshot
7.13.3. Operating business segment
7.13.4. Product Portfolio

7.14. OMRON HEALTHCARE EUROPE B.V.

7.14.1. Company overview
7.14.2. Company snapshot
7.14.3. Product Portfolio

7.15. QARDIO, INC.

7.15.1. Company overview
7.15.2. Company snapshot
7.15.3. Product Portfolio"
 

Select License Type
  • Single User License $5370 USD
  • Multi-User License $6450 USD
  • Corporate User License $8995 USD

Our Clients

  • +1 518-300-1215Mon-Fri, 24Hrs
  • [email protected]We reply within an hours
  • Albany,
    NY, USA.